Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1996 Apr 16;93(8):3161–3163. doi: 10.1073/pnas.93.8.3161

Facilitating oligonucleotide delivery: helping antisense deliver on its promise.

A M Gewirtz 1, C A Stein 1, P M Glazer 1
PMCID: PMC39574  PMID: 8622906

Full text

PDF
3161

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baskerville S., Ellington A. D. RNA structure. Describing the elephant. Curr Biol. 1995 Feb 1;5(2):120–123. doi: 10.1016/s0960-9822(95)00030-3. [DOI] [PubMed] [Google Scholar]
  2. Beal P. A., Dervan P. B. Second structural motif for recognition of DNA by oligonucleotide-directed triple-helix formation. Science. 1991 Mar 15;251(4999):1360–1363. doi: 10.1126/science.2003222. [DOI] [PubMed] [Google Scholar]
  3. Beltinger C., Saragovi H. U., Smith R. M., LeSauteur L., Shah N., DeDionisio L., Christensen L., Raible A., Jarett L., Gewirtz A. M. Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J Clin Invest. 1995 Apr;95(4):1814–1823. doi: 10.1172/JCI117860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bennett C. F., Chiang M. Y., Chan H., Shoemaker J. E., Mirabelli C. K. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol. 1992 Jun;41(6):1023–1033. [PubMed] [Google Scholar]
  5. Bongartz J. P., Aubertin A. M., Milhaud P. G., Lebleu B. Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide. Nucleic Acids Res. 1994 Nov 11;22(22):4681–4688. doi: 10.1093/nar/22.22.4681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Boussif O., Lezoualc'h F., Zanta M. A., Mergny M. D., Scherman D., Demeneix B., Behr J. P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7297–7301. doi: 10.1073/pnas.92.16.7297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Citro G., Perrotti D., Cucco C., D'Agnano I., Sacchi A., Zupi G., Calabretta B. Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7031–7035. doi: 10.1073/pnas.89.15.7031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Clarenc J. P., Degols G., Leonetti J. P., Milhaud P., Lebleu B. Delivery of antisense oligonucleotides by poly(L-lysine) conjugation and liposome encapsulation. Anticancer Drug Des. 1993 Feb;8(1):81–94. [PubMed] [Google Scholar]
  9. Derossi D., Joliot A. H., Chassaing G., Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem. 1994 Apr 8;269(14):10444–10450. [PubMed] [Google Scholar]
  10. Gao W. Y., Storm C., Egan W., Cheng Y. C. Cellular pharmacology of phosphorothioate homooligodeoxynucleotides in human cells. Mol Pharmacol. 1993 Jan;43(1):45–50. [PubMed] [Google Scholar]
  11. Gewirtz A. M., Anfossi G., Venturelli D., Valpreda S., Sims R., Calabretta B. G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. Science. 1989 Jul 14;245(4914):180–183. doi: 10.1126/science.2665077. [DOI] [PubMed] [Google Scholar]
  12. Gewirtz A. M., Calabretta B. A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science. 1988 Dec 2;242(4883):1303–1306. doi: 10.1126/science.2461588. [DOI] [PubMed] [Google Scholar]
  13. Hijiya N., Zhang J., Ratajczak M. Z., Kant J. A., DeRiel K., Herlyn M., Zon G., Gewirtz A. M. Biologic and therapeutic significance of MYB expression in human melanoma. Proc Natl Acad Sci U S A. 1994 May 10;91(10):4499–4503. doi: 10.1073/pnas.91.10.4499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hélène C. Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides. Eur J Cancer. 1991;27(11):1466–1471. doi: 10.1016/0277-5379(91)90033-a. [DOI] [PubMed] [Google Scholar]
  15. Hélène C. The anti-gene strategy: control of gene expression by triplex-forming-oligonucleotides. Anticancer Drug Des. 1991 Dec;6(6):569–584. [PubMed] [Google Scholar]
  16. Ing N. H., Beekman J. M., Kessler D. J., Murphy M., Jayaraman K., Zendegui J. G., Hogan M. E., O'Malley B. W., Tsai M. J. In vivo transcription of a progesterone-responsive gene is specifically inhibited by a triplex-forming oligonucleotide. Nucleic Acids Res. 1993 Jun 25;21(12):2789–2796. doi: 10.1093/nar/21.12.2789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kabanov A. V., Kabanov V. A. DNA complexes with polycations for the delivery of genetic material into cells. Bioconjug Chem. 1995 Jan-Feb;6(1):7–20. doi: 10.1021/bc00031a002. [DOI] [PubMed] [Google Scholar]
  18. Maher L. J., 3rd, Wold B., Dervan P. B. Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation. Science. 1989 Aug 18;245(4919):725–730. doi: 10.1126/science.2549631. [DOI] [PubMed] [Google Scholar]
  19. Melton D. W. Gene targeting in the mouse. Bioessays. 1994 Sep;16(9):633–638. doi: 10.1002/bies.950160907. [DOI] [PubMed] [Google Scholar]
  20. Metcalf D. Blood. Thrombopoietin--at last. Nature. 1994 Jun 16;369(6481):519–520. doi: 10.1038/369519a0. [DOI] [PubMed] [Google Scholar]
  21. Methia N., Louache F., Vainchenker W., Wendling F. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood. 1993 Sep 1;82(5):1395–1401. [PubMed] [Google Scholar]
  22. Noonberg S. B., François J. C., Garestier T., Hélène C. Effect of competing self-structure on triplex formation with purine-rich oligodeoxynucleotides containing GA repeats. Nucleic Acids Res. 1995 Jun 11;23(11):1956–1963. doi: 10.1093/nar/23.11.1956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Postel E. H., Flint S. J., Kessler D. J., Hogan M. E. Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8227–8231. doi: 10.1073/pnas.88.18.8227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ratajczak M. Z., Kant J. A., Luger S. M., Hijiya N., Zhang J., Zon G., Gewirtz A. M. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11823–11827. doi: 10.1073/pnas.89.24.11823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ratajczak M. Z., Kuczynski W. I., Sokol D. L., Moore J. S., Pletcher C. H., Jr, Gewirtz A. M. Expression and physiologic significance of Kit ligand and stem cell tyrosine kinase-1 receptor ligand in normal human CD34+, c-Kit+ marrow cells. Blood. 1995 Sep 15;86(6):2161–2167. [PubMed] [Google Scholar]
  26. Ratajczak M. Z., Luger S. M., DeRiel K., Abrahm J., Calabretta B., Gewirtz A. M. Role of the KIT protooncogene in normal and malignant human hematopoiesis. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1710–1714. doi: 10.1073/pnas.89.5.1710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wang G., Levy D. D., Seidman M. M., Glazer P. M. Targeted mutagenesis in mammalian cells mediated by intracellular triple helix formation. Mol Cell Biol. 1995 Mar;15(3):1759–1768. doi: 10.1128/mcb.15.3.1759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wang G., Seidman M. M., Glazer P. M. Mutagenesis in mammalian cells induced by triple helix formation and transcription-coupled repair. Science. 1996 Feb 9;271(5250):802–805. doi: 10.1126/science.271.5250.802. [DOI] [PubMed] [Google Scholar]
  29. Wang S., Lee R. J., Cauchon G., Gorenstein D. G., Low P. S. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3318–3322. doi: 10.1073/pnas.92.8.3318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Willnow T. E., Herz J. Homologous recombination for gene replacement in mouse cell lines. Methods Cell Biol. 1994;43(Pt A):305–334. doi: 10.1016/s0091-679x(08)60610-x. [DOI] [PubMed] [Google Scholar]
  31. Wu G. Y., Wu C. H. Specific inhibition of hepatitis B viral gene expression in vitro by targeted antisense oligonucleotides. J Biol Chem. 1992 Jun 25;267(18):12436–12439. [PubMed] [Google Scholar]
  32. Zatloukal K., Wagner E., Cotten M., Phillips S., Plank C., Steinlein P., Curiel D. T., Birnstiel M. L. Transferrinfection: a highly efficient way to express gene constructs in eukaryotic cells. Ann N Y Acad Sci. 1992 Oct 28;660:136–153. doi: 10.1111/j.1749-6632.1992.tb21066.x. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES